Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001301396-25-000008·BIORA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
BIORA THERAPEUTICS, INC.
Common Stock · CUSIP: 74319F404
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Context Capital Management, LLC
Shares: 22,025.00 · Class: 0.5%
- Michael S. Rosen
Shares: 22,025.00 · Class: 0.5%
- William D. Fertig
Shares: 22,025.00 · Class: 0.5%
- Charles E. Carnegie
Shares: 22,025.00 · Class: 0.5%
- Context Partners Master Fund, L.P.
Shares: 22,025.00 · Class: 0.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001301396-25-000008
- Form type
- SCHEDULE 13G/A
- Filer
- BIORA THERAPEUTICS, INC.
- CIK
- CIK 1580063
- Filed
- Jul 10, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership